Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.
Misoprostol is the primary drug of choice for medical termination. It is not only cheap, but also stable at room temperature and easily available worldwide. It is indicated for the treatment of gastritis, but is widely used off-label for a variety of indications in the practice of obstetrics and gynecology, including medication abortion, induction of labor, and the treatment of postpartum hemorrhage. The optimal dosage and route of administration have not been well defined and vary with physicians. The potency of misoprostol's effect varies with dosage, route of administration and dosing interval; both maternal and fetal factors may, to certain extent, affect the abortion interval. This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pregnancy | Women who underwent termination of pregnancy at second trimester due to a variety of causes |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Successful termination rate by Cytotec. | 1 week |
| Measure | Description | Time Frame |
|---|---|---|
| Factors affecting abortion interval by cytotec. | To identify the factors affecting termination interval Cox regression model. | 1 week |
Not provided
Inclusion Criteria:
1.All female patients who were admitted for medical termination of second-trimester pregnancy
Exclusion Criteria:
1. Patients who are allergy to Cytotec.
Not provided
Not provided
This is a single-center, retrospective chart review study. All female patients who were admitted for medical termination of second-trimester pregnancy from January 2008 to May 2013, at the Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital were recruited.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sheng-Mou Hsiao, MD | Far Eastern Memorial Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Far Eastern Memorial Hospital | New Taipei | Taiwan | 220 | Taiwan |
Not provided
Not provided
Not provided
Not provided